KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
KBIO was delisted on the 16th of December, 2015.
48 hedge funds and large institutions have $52.2M invested in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in 2014 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 9 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 12
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
4% more funds holding
Funds holding: 46 → 48 (+2)
41% less capital invested
Capital invested by funds: $89.1M → $52.2M (-$36.9M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$10.1M |
| 2 |
First Eagle Investment Management
New York
|
+$3.16M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$1.94M |
| 4 |
Millennium Management
New York
|
+$1.22M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$942K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
-$11.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.33M |
| 3 |
LBH
Lehman Brothers Holdings
New York
|
-$2.91M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$2.74M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
-$2.34M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
51
Sabby Management
Miami Beach,
Florida
| – | -$356K | -10,081 | Closed |
|
|
DS
52
DRW Securities
Chicago,
Illinois
| – | -$88K | -2,500 | Closed |
|
|
TAM
53
Tocqueville Asset Management
New York
| – | -$75K | -2,125 | Closed |
|
54
Morgan Stanley
New York
| – | -$14.7K | -508 | -98% |
|
55
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$2 | -54 | Closed |
|
56
Bank of America
Charlotte,
North Carolina
| – | -$637 | -22 | -88% |
|
57
BNP Paribas Financial Markets
Paris,
France
| – | -$681 | -19 | Closed |
|
KBIO Hedge Fund Activity: Q1 2014 in Review
48 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) for Q1 2014, worth a combined $52.2M — down 41% from $89.1M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new KBIO positions and 9 closed out — a net gain of 2 holders — while 20 added to existing stakes and 12 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $10.1M. The largest seller was MPM Asset Management, exiting entirely with an estimated $11.6M sold.
- 48 institutional investors held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) as of Q1 2014, up from 46 in Q4 2013.
- Funds reported $52.2M of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) stock for Q1 2014, down 41% quarter-over-quarter.
- 11 funds opened new KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) positions in Q1 2014 and 9 closed out, a net change of +2 holders.
- The largest KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) buyer in Q1 2014 was Deerfield Management, an estimated $10.1M added.
- The largest KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) seller in Q1 2014 was MPM Asset Management, an estimated $11.6M sold.
Based on aggregated 13F filings for Q1 2014.